Inspira Health’s operating margin drops to -5.2% in Q3

Vineland, N.J.-based Inspira Health reported a $51.6 million operating loss (-5.2% margin) in the third quarter of 2024, falling from a $31.6 million operating loss (-3.4% margin) during the same period in 2023, according to its Nov. 14 financial report.

Advertisement

Here are four things to know:

1. Inspira’s net income was $42.6 million in the third quarter of 2024, up from $3.6 million during the same period last year.

2. The system saw a total revenue of $982.7 million in the three months ended Sept. 30, 2024, up from $933.9 million in the three months ended Sept. 30, 2023. 

3. Total expenses for Inspira were $1 billion in the third quarter of 2024, up from $965.6 million in the third quarter of 2023.

4. Inspira had 260.7 days of cash on hand and $659.4 million in long-term debt on Sept. 30, 2024. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.